Johnson & Johnson Common Stock — Earnings

Past earnings

1. Wed · Jul 15EPS beat-2.7%on the day
   EPS $2.9 vs est $2.84Revenue $25.3B

   EPS of $2.9 beat the $2.84 estimate (+2%); revenue came in at $25.3B (+1% vs est). Shares fell 2.7% on the release day.

2. Tue · Apr 14EPS beat+0.9%on the day
   EPS $2.7 vs est $2.68Revenue $24.1B

   EPS of $2.7 beat the $2.68 estimate (+1%); revenue came in at $24.1B (+2% vs est). Shares rose 0.9% on the release day.

3. Wed · Jan 21EPS beat-0.1%on the day
   EPS $2.46 vs est $2.46Revenue $24.6B

   EPS of $2.46 beat the $2.46 estimate (+0%); revenue came in at $24.6B (+2% vs est). Shares fell 0.1% on the release day.

4. Tue · Oct 14EPS beat+0%on the day
   EPS $2.8 vs est $2.76Revenue $24.0B

   EPS of $2.8 beat the $2.76 estimate (+1%); revenue came in at $24.0B (+1% vs est). Shares rose 0% on the release day.

5. Wed · Jul 16EPS beat+6.2%on the day
   EPS $2.77 vs est $2.68Revenue $23.7B

   EPS of $2.77 beat the $2.68 estimate (+3%); revenue came in at $23.7B (+4% vs est). Shares rose 6.2% on the release day.

On the AI radar now

Live market issues involving JNJ

• 1J&J Wins Talc Lawsuit, Clears Key Cancer-Liability OverhangCourt rules talc did not cause cancer in three plaintiffs›
• 5Pfizer Rebounds After Oncology Drug Miss and CFO DeparturePFE stabilizes on yield appeal despite pipeline and mgmt uncertainty›

JNJ related news

• Intuitive Surgical (ISRG): Piper Sandler Flags Long-Term Growth CatalystsSat · Jun 27
• AbbVie Skyrizi Wins Pediatric Psoriatic Disease Label, Extending Post-Humira Runway (ABBV)Fri · Jun 26
• BKDV ETF Explained: How Large-Cap Value Fits a Growth-Heavy PortfolioFri · Jun 26
• Fed Holds Rates Steady: What It Means for Dividend Stocks Like O, JNJ, KOSun · Jun 21
• US Tariff Probe Into Germany Drug Pricing: What It Means for PFE, MRK, LLY Pharma StocksFri · Jun 19